Navigation Links
ScreenCancer Adds InSure(R) FIT(TM) Colorectal Cancer Screening Test to European Cancer Screening Program
Date:2/26/2009

by other FITs (fecal immunochemical tests) or FOBTs (fecal occult blood tests) - and does not require any change in patient diet or medication. In one study, patients were 66% more compliant in completing their InSure FIT test compared to a leading guaiac-based FOBT test.[3] Information about the InSure FIT test is available at http://www.doyouhavetheguts.com.

A recent interim study conducted at the Flinders Centre for Innovation in Cancer (Australia) and presented at the annual Digestive Disease Week Conference in May 2008 found that, in patients with a family or personal history of colorectal cancer or adenoma who completed an annual FIT, detection of cancerous lesions occurred an average of 26.5 months earlier than would have occurred during the three- or five-year study-required colonoscopy alone. Detection of precancerous lesions in this group occurred 18.4 months earlier.[4]

"Quest Diagnostics is committed to expanding the number of people getting screened annually for colorectal cancer, and ScreenCancer is a valued partner in that endeavor," remarked Paul Rust, Quest Diagnostics' Vice President, Point of Care Testing. "ScreenCancer's introduction of an innovative, comprehensive cancer screening program in the European commercial market, combined with tests such as the InSure FIT colorectal cancer screening test, promise to help improve cancer screening rates, and as a result, through early detection, help save lives."

About ScreenCancer, AS

ScreenCancer AS provides cancer screening management services to self-insured employers and individuals. ScreenCancer offers a private alternative where little or no public cancer screening program exists. With a panel of the leading screening tests for several major cancers, and clinical follow-up by experts in the field, ScreenCancer provides a method for employers and individuals t
'/>"/>

SOURCE ScreenCancer AS
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers
2. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
3. Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers
4. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
5. GeneNews appoints Canadian Colorectal Cancer Advisory Board
6. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
7. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
8. NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER
9. GeneNews launches worlds first blood test for colorectal cancer screening
10. Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
11. Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Milwaukee, Wisc. (PRWEB) May 21, 2013 ... equipment parts distributor , will be exhibiting for ... the Advancement of Medical Instrumentation (AAMI) 2013 Conference ... manage, purchase, support, distribute, and manufacture healthcare technologies. ... 1-3 in Long Beach, California. , The ...
(Date:5/21/2013)... Branchburg, NJ (PRWEB) May 21, 2013 ... enhancement industry, has appointed Dale Braddy to Southeastern USA ... proactively bolster its sales muscle in the Southeast. ... a food ingredient brokerage and supplier to food processors ... past 13 years in the food industry and has ...
(Date:5/21/2013)... May 21, 2013 Smarter Security, Inc., ... solutions, today announced that Genzyme, a Sanofi company and ... Door Detective® CL for a multi-use facility in the ... four other Genzyme buildings, this latest order underscores the ... tailgate detection device improving doorway access control. ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
... 20 Turtle Island Soup has launched ... with ingredients shown to have,important health benefits, ... The new Souper Food soups are ... 6086),( http://www.ganedenlabs.com/ourScience.html ), a probiotic that has ...
... from Phase One of Two-Phase Examination of U.S. Asthma ... 20 /PRNewswire-FirstCall/,-- Nearly half of adult Americans with asthma ... responded to a nationally representative survey do,not have their ... was presented today at the International Conference of the ...
... affiliations, Novation represents 49 percent of admissions and ... 52 percent of total surgeries in the United States, ... announced it has signed a contract with Novation, the,industry,s ... (UHC) and Provista, LLC. Through its,affiliations, Novation represents 49 ...
Cached Biology Technology:Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 2Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 3Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 2Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 3Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization 2Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization 3Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization 4
(Date:5/20/2013)... National Science Foundation (NSF) planning grant will help establish ... joint program of the University of Illinois at Urbana-Champaign ... "CARD will be devoted to research in drying moist, ... forestry and paper products; chemical products; textiles; and biopharmaceuticals," ... food science and human nutrition and the Illinois site ...
(Date:5/19/2013)... reports that white men and women of European descent ... and lesser toe deformities, including hammer or claw toe. ... the heritability of foot disorders in humansappear in ... Wiley on behalf of the American College of Rheumatology ... as 60% of older adults have foot disorders which ...
(Date:5/18/2013)... (May 18, 2013) Research presented today at Digestive ... research, with findings about the impact of coffee on ... , While coffee consumption recently has been associated with ... even a few more cups of java each month ... liver disease. Researchers at the Mayo Clinic, Rochester, MN, ...
Breaking Biology News(10 mins):NSF approves planning grant for Center for Advanced Research in Drying 2Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2
... a castle gate, multiple genetic defenders cooperate to protect ... new study. Powdery mildew is a common fungal infection ... many crops such as barley and wheat, and horticultural ... Shauna Somerville and Mónica Stein of the Carnegie Institution's ...
... fingerprints and march to the beat of subtly ... bioengineering researchers at the University of California, San ... the underlying sources of variation at the basic ... and variations between identical cells. , "Scientists might ...
... ingredient, tetrahydrocannabinol--has a well-documented tendency to stimulate ... property to cannabinoid receptors in the brain, ... neural circuitry underlying this effect. , Understanding ... blocking the cannabinoid receptor, CB1, offers a ...
Cached Biology News:Genetic defenders protect crops from fungal disease 2Genetic defenders protect crops from fungal disease 3Researchers quantify more noise in gene expression 2Researchers quantify more noise in gene expression 3Machinery of the 'marijuana munchies' 2
Carrier-Free Recombinant Human Flt-3/Flk-2 Ligand (Flt3/Flk2 Ligand, Flt3L, Flt3-L, Flk2L, Flk2-L) 100 ug...
... Antitumour agent and DNA-topoisomersae II inhibitor (IC50 ... C 29 H 32 O ... 588.55658 Store at: ... Solubility: Soluble to ...
NAP-2 (5C7)...
golgi reassembly stacking protein 2, 55kDa...
Biology Products: